JP2020532546A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020532546A5 JP2020532546A5 JP2020512589A JP2020512589A JP2020532546A5 JP 2020532546 A5 JP2020532546 A5 JP 2020532546A5 JP 2020512589 A JP2020512589 A JP 2020512589A JP 2020512589 A JP2020512589 A JP 2020512589A JP 2020532546 A5 JP2020532546 A5 JP 2020532546A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- composition
- molar ratio
- cationic lipid
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023115742A JP2023138526A (ja) | 2017-08-31 | 2023-07-14 | 組織特異的送達用のカチオン性脂質組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762552783P | 2017-08-31 | 2017-08-31 | |
| US62/552,783 | 2017-08-31 | ||
| PCT/US2018/042555 WO2019045897A1 (en) | 2017-08-31 | 2018-07-17 | CATIONIC LIPIDIC COMPOSITIONS FOR TISSUE-SPECIFIC ADMINISTRATION |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023115742A Division JP2023138526A (ja) | 2017-08-31 | 2023-07-14 | 組織特異的送達用のカチオン性脂質組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020532546A JP2020532546A (ja) | 2020-11-12 |
| JP2020532546A5 true JP2020532546A5 (enExample) | 2022-12-09 |
| JP7379325B2 JP7379325B2 (ja) | 2023-11-14 |
Family
ID=63104088
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512589A Active JP7379325B2 (ja) | 2017-08-31 | 2018-07-17 | 組織特異的送達用のカチオン性脂質組成物 |
| JP2023115742A Pending JP2023138526A (ja) | 2017-08-31 | 2023-07-14 | 組織特異的送達用のカチオン性脂質組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023115742A Pending JP2023138526A (ja) | 2017-08-31 | 2023-07-14 | 組織特異的送達用のカチオン性脂質組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20190060482A1 (enExample) |
| EP (1) | EP3675826B1 (enExample) |
| JP (2) | JP7379325B2 (enExample) |
| CN (1) | CN111065377A (enExample) |
| AU (1) | AU2018324345B2 (enExample) |
| CA (1) | CA3073851A1 (enExample) |
| LT (1) | LT3675826T (enExample) |
| WO (1) | WO2019045897A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11690921B2 (en) * | 2018-05-18 | 2023-07-04 | Sangamo Therapeutics, Inc. | Delivery of target specific nucleases |
| PT4223886T (pt) | 2019-04-16 | 2024-12-20 | Genfit | Composições e métodos para a estabilização de micro-arn |
| JP7699552B2 (ja) * | 2019-07-03 | 2025-06-27 | ファクター バイオサイエンス インコーポレイテッド | カチオン性脂質及びその使用 |
| US10501404B1 (en) | 2019-07-30 | 2019-12-10 | Factor Bioscience Inc. | Cationic lipids and transfection methods |
| EP3865122A1 (en) * | 2020-02-11 | 2021-08-18 | Pantherna Therapeutics GmbH | Lipid composition and use thereof for delivery of a therapeutically active agent to endothelium |
| JP2025524562A (ja) | 2022-06-30 | 2025-07-30 | ライフ テクノロジーズ コーポレーション | インビボ送達のための脂質組成物 |
| US20240263196A1 (en) | 2022-12-29 | 2024-08-08 | Life Technologies Corporation | Lipid Compositions and Methods for Delivery to Immune Cells |
| CN119997938A (zh) * | 2023-06-05 | 2025-05-13 | 安徽医科大学第一附属医院 | 肺靶向纳米胶束、制备方法及应用 |
| TW202543585A (zh) | 2024-03-08 | 2025-11-16 | 美商健臻公司 | 脂質奈米粒子 |
| WO2026030375A2 (en) | 2024-07-30 | 2026-02-05 | Genzyme Corporation | Lipid nanoparticles and methods of manufacture and use thereof |
| CN118576568B (zh) * | 2024-08-06 | 2024-11-26 | 北京悦康科创医药科技股份有限公司 | 一种药物组合物及其制备方法和应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
| US6028077A (en) | 1997-04-15 | 2000-02-22 | Rinehart; Kenneth L. | Crambescidin compounds |
| EP1829856A3 (en) * | 1998-11-12 | 2009-02-25 | Invitrogen Corporation | Transfection reagents |
| JP2004512345A (ja) | 2000-11-02 | 2004-04-22 | スミスクライン・ビーチャム・コーポレイション | 受容体アンタゴニスト−脂質コンジュゲートおよびそれを含有するデリバリービヒクル |
| AU2002360762A1 (en) | 2001-12-19 | 2003-07-09 | Alza Corporation | Liposomal tumor necrosis factor compositions |
| WO2005120152A2 (en) | 2004-06-07 | 2005-12-22 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods of use |
| US20130189364A1 (en) | 2004-07-09 | 2013-07-25 | Robert Sabin | Compositions and methods of potentiating adjuvant pharmaceuticals targeting latent viral infections |
| GB0418172D0 (en) | 2004-08-13 | 2004-09-15 | Ic Vec Ltd | Vector |
| WO2009111088A2 (en) * | 2008-01-02 | 2009-09-11 | The Johns Hopkins University | Antitumor immunization by liposomal delivery of vaccine to the spleen |
| EP2464336A4 (en) * | 2009-08-14 | 2013-11-20 | Alnylam Pharmaceuticals Inc | COMPOSITIONS FORMULATED IN LIPIDS AND METHODS OF INHIBITING THE EXPRESSION OF EBOLA VIRUS GENE |
| AU2010334911A1 (en) * | 2009-12-23 | 2012-07-12 | Novartis Ag | Lipids, lipid compositions, and methods of using them |
| JP2014508102A (ja) * | 2010-11-15 | 2014-04-03 | ライフ テクノロジーズ コーポレーション | アミン含有トランスフェクション試薬ならびにそれを生成および使用するための方法 |
| PT2717893T (pt) * | 2011-06-08 | 2019-08-20 | Translate Bio Inc | Composições de nanopartículas lipídicas e métodos para transferência de arnm |
| GR1008018B (el) | 2012-09-06 | 2013-10-29 | Ιδρυμα Ιατροβιολογικων Ερευνων Ακαδημιας Αθηνων, | Λιπιδικα συμπλοκα αποτελουμενα απο ανιονικα λυσο-λιπιδια και η εφαρμογη αυτων |
| CN103296033B (zh) | 2013-05-28 | 2016-05-11 | 京东方科技集团股份有限公司 | 一种阵列基板及其制作方法 |
| JP2016528890A (ja) * | 2013-07-09 | 2016-09-23 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ＣＲＩＳＰＲ／Ｃａｓ系を用いるゲノム編集の治療用の使用 |
| SG10201811729PA (en) | 2013-12-12 | 2019-02-27 | Life Technologies Corp | Membrane-penetrating peptides to enhance transfection and compositions and methods for using same |
| WO2016011203A1 (en) * | 2014-07-15 | 2016-01-21 | Life Technologies Corporation | Compositions with lipid aggregates and methods for efficient delivery of molecules to cells |
| ES2949540T3 (es) | 2015-06-19 | 2023-09-29 | Massachusetts Inst Technology | 2,5-piperazinadionas sustituidas con alquenilo y su uso en composiciones para suministrar un agente a un sujeto o una célula |
| JP6715325B2 (ja) * | 2015-06-26 | 2020-07-01 | スーチョウ リボ ライフ サイエンス カンパニー、リミテッドＳｕｚｈｏｕ Ｒｉｂｏ Ｌｉｆｅ Ｓｃｉｅｎｃｅ Ｃｏ．， Ｌｔｄ． | ｓｉＲＮＡ、ｓｉＲＮＡを含む医薬組成物及び結合体、並びにそれらの応用 |
| US10829787B2 (en) | 2015-10-14 | 2020-11-10 | Life Technologies Corporation | Ribonucleoprotein transfection agents |
| US11690921B2 (en) * | 2018-05-18 | 2023-07-04 | Sangamo Therapeutics, Inc. | Delivery of target specific nucleases |
| EP3846822A4 (en) * | 2018-09-04 | 2022-07-06 | The Board Of Regents Of The University Of Texas System | COMPOSITIONS AND METHODS FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACIDS |
-
2018
- 2018-07-17 CA CA3073851A patent/CA3073851A1/en active Pending
- 2018-07-17 CN CN201880056879.8A patent/CN111065377A/zh active Pending
- 2018-07-17 US US16/038,107 patent/US20190060482A1/en not_active Abandoned
- 2018-07-17 LT LTEPPCT/US2018/042555T patent/LT3675826T/lt unknown
- 2018-07-17 EP EP18749995.9A patent/EP3675826B1/en active Active
- 2018-07-17 JP JP2020512589A patent/JP7379325B2/ja active Active
- 2018-07-17 WO PCT/US2018/042555 patent/WO2019045897A1/en not_active Ceased
- 2018-07-17 AU AU2018324345A patent/AU2018324345B2/en active Active
-
2021
- 2021-07-16 US US17/378,466 patent/US12521447B2/en active Active
-
2023
- 2023-07-14 JP JP2023115742A patent/JP2023138526A/ja active Pending
-
2025
- 2025-12-10 US US19/415,525 patent/US20260108623A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7641308B2 (ja) | Ｒｎａ送達のためのイオン化可能なカチオン性脂質 | |
| US20260108623A1 (en) | Cationic lipid compositions for tissue-specific delivery | |
| JP7778711B2 (ja) | ポリサルコシンを含むｒｎａ粒子 | |
| JP2024534697A5 (enExample) | ||
| CN104428005A (zh) | 用于反义寡核苷酸递送的脂质纳米颗粒组合物 | |
| CN1295465A (zh) | 脂质体组合物和喹诺酮的给药方法 | |
| CN108024960A (zh) | 含有阴离子药物的药物组合物及其制备方法 | |
| US20190328665A1 (en) | Liposome compositions encapsulating modified cyclodextrin complexes and uses thereof | |
| JP7821776B2 (ja) | 効率的な核酸送達のための担体 | |
| JP7829485B2 (ja) | がんの処置において有用なＴｏｌｌ様受容体（「ＴＬＲ」）アゴニストプロドラッグを含有する製剤化および／または共製剤化リポソーム組成物ならびにその方法 | |
| US20240209397A1 (en) | Thermally Stable Lipid-Nucleic Acid Molecule Formulations Utilising Metal Organic Framework (MOF) Shells | |
| JP2023518944A5 (enExample) | ||
| WO2023246218A1 (zh) | 用于核酸递送的可电离脂质及其组合物 | |
| JP2025501905A (ja) | イオン化脂質、脂質ナノ粒子、及びこれらの使用 | |
| KR102921785B1 (ko) | 핵산 전달용 사이클로알칸계 지질 화합물 및 이를 포함하는 지질 나노입자 | |
| WO2024017254A1 (zh) | 氨基脂质化合物、其制备方法和应用 | |
| WO2014030601A1 (ja) | アニオン性を有する新規ナノバブルポリ－リポ・プレックスの製造方法 | |
| JP2025516637A5 (enExample) | ||
| US12064512B2 (en) | Silyl lipids suitable for enhanced delivery of anti-viral therapeutics | |
| US20220378936A1 (en) | Delivery system complexes comprising a precipitate of an active agent and methods of use | |
| JP2003522203A (ja) | 天然に存在しない核酸組成物、核酸を細胞中にトランスフェクションするのに有用な処方物の調製のためのそれらの使用、および応用 | |
| KR20260071091A (ko) | 신규 이온화 지질 및 이를 포함하는 지질 나노입자 | |
| CN119424366A (zh) | 靶向次级淋巴器官的脂质纳米颗粒及其制备方法和用途 | |
| CA3258341A1 (en) | Nucleic acids encoding a constituently active cyclic GMP-AMP synthase and associated immunogenic delivery vehicles | |
| WO2023239593A1 (en) | Method for sustained delivery of mrna vaccines |